Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
9.03
-1.98 (-17.98%)
Jun 10, 2026, 10:51 AM EDT - Market open
Eloxx Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -8.04 | -6 | -3.14 | -17.05 | -36.07 | -66.73 |
Depreciation & Amortization | - | - | 0.16 | 0.81 | 0.7 | 0.96 |
Other Amortization | 0.02 | 0.25 | 0.47 | 0.26 | 0.54 | 0.42 |
Loss (Gain) From Sale of Assets | -0 | -0 | -0.04 | -0.29 | - | 0.08 |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.04 | 22.67 |
Stock-Based Compensation | 0.26 | 0.24 | 0.54 | 1.97 | 3.02 | 9.17 |
Other Operating Activities | -1.41 | -1.33 | -0.35 | -0.88 | 0.05 | -0.54 |
Change in Accounts Receivable | 0.25 | 2.72 | -2.72 | - | - | - |
Change in Accounts Payable | -2.18 | -2.63 | -0.35 | 2.68 | 1.64 | -0.32 |
Change in Other Net Operating Assets | -1.88 | 0.44 | 0.72 | -1.84 | -1.76 | -0.72 |
Operating Cash Flow | -12.98 | -6.33 | -4.72 | -14.34 | -31.85 | -35 |
Capital Expenditures | - | - | - | - | -0.07 | -0.09 |
Sale of Property, Plant & Equipment | 0 | 0 | 0.04 | 0.31 | - | - |
Cash Acquisitions | - | - | - | - | - | 2.15 |
Investing Cash Flow | 0 | 0 | 0.04 | 0.31 | -0.07 | 2.06 |
Short-Term Debt Issued | - | - | 0.38 | 0.43 | - | - |
Long-Term Debt Issued | - | 2.87 | 3.67 | - | - | 11.87 |
Total Debt Issued | 2.48 | 2.87 | 4.05 | 0.43 | - | 11.87 |
Short-Term Debt Repaid | - | -0.3 | - | - | - | - |
Long-Term Debt Repaid | - | -1.26 | -0.61 | -9.4 | - | -11.38 |
Total Debt Repaid | -0.3 | -1.56 | -0.61 | -9.4 | - | -11.38 |
Net Debt Issued (Repaid) | 2.18 | 1.31 | 3.44 | -8.97 | - | 0.49 |
Issuance of Common Stock | 7.03 | - | - | 4.89 | - | 47.74 |
Repurchase of Common Stock | - | - | - | - | - | -0.36 |
Other Financing Activities | 9.69 | 9.69 | - | - | 8.81 | 2.92 |
Financing Cash Flow | 18.9 | 11 | 3.44 | -4.08 | 8.81 | 50.79 |
Net Cash Flow | 5.91 | 4.68 | -1.24 | -18.11 | -23.1 | 17.84 |
Free Cash Flow | -12.98 | -6.33 | -4.72 | -14.34 | -31.91 | -35.09 |
Free Cash Flow Margin | - | - | -74.15% | - | - | - |
Free Cash Flow Per Share | -6.09 | -5.64 | -13.80 | -61.37 | -162.04 | -220.68 |
Cash Interest Paid | - | 0.03 | 0.14 | 0.99 | 1.37 | 0.73 |
Levered Free Cash Flow | - | -4.9 | -3.47 | -6.47 | -17.96 | -14.61 |
Unlevered Free Cash Flow | - | -4.49 | -3.22 | -6.01 | -17.28 | -14.25 |
Change in Working Capital | -3.81 | 0.52 | -2.36 | 0.84 | -0.12 | -1.04 |